by Acellular dermal matrices are processed human or animal-derived dermal tissues that are acellular yet retain the collagenous extracellular matrix. These tissues provide a scaffold that allows for cellular repopulation and revascularization for tissue reconstruction. The acellular dermal matrices are increasingly being used in breast reconstruction surgeries, chronic skin ulcers, diabetic foot ulcers and other soft tissue reconstructions. The advantages of acellular dermal matrices include biocompatibility, biodegradability, ability to revascularize and regenerate dermal architecture. The growing geriatric population suffering from chronic wounds and rising cases of breast cancer are driving the demand for advanced wound care products and reconstructive surgeries, which in turn is fueling the growth of the acellular dermal matrices market.
The Global Acellular Dermal Matrices Market is estimated to be valued at US$ 10.14 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period of 2024 to 2030.
Key Takeaways
Key players operating in the Acellular Dermal Matrices are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. These players are focusing on new product launches and regional expansions to consolidate their market positions.
The rising prevalence of non-healing wounds due to increasing incidence of diabetes and obesity is presenting significant growth opportunities for players in the acellular dermal matrices market. Additionally, growing use of acellular dermal matrices in reconstructive and plastic surgeries is anticipated to further drive the market growth over the forecast period.
Globally, North America dominated the acellular dermal matrices market in 2020 owing to rising healthcare expenditure, developed healthcare infrastructure and high adoption of advanced wound care therapies. However, Asia Pacific is expected to witness highest growth during the forecast period due to growing medical tourism industry, rising healthcare spending and increasing focus of key players on emerging markets in the region.
Market Drivers
Rising geriatric population subjected to age-related chronic conditions is a major driver for the Acellular Dermal Matrices Market Growth . According to the UN data, the population aged 65 years and older is projected to grow from 703 million in 2019 to 1.5 billion in 2050 globally. Aged people are more prone to develop chronic wounds which is projected to drive the adoption of acellular dermal matrices. Additionally, increasing number of breast reconstruction surgeries using acellular dermal matrices are witnessed owing to rising cases of breast cancer globally. This is anticipated to further propel the market growth over the forecast period.
PEST Analysis
Political: The Acellular Dermal Matrices (ADM) market is regulated by different government regulations and standards set by regulatory bodies. Manufacturers need to obtain the regulatory approvals before marketing their products.
Economic: With growing per capita incomes and increasing healthcare spends, demand for advanced treatment options like ADM is rising globally. However, high costs associated with these matrices can restraint market growth in price-sensitive regions.
Social: Aging population and increasing prevalence of chronic wounds, burn injuries, and soft tissue injuries are fueling the need for safe and effective wound healing substitutes like ADM. Healthcare professionals and patients are also more aware about the benefits offered by these matrices over conventional treatment options.
Technological: Manufacturers are investing in R&D to develop advanced bioengineered matrices with enhanced strength, durability, and handling properties. Technologies like 3D printing are being explored to customize matrices as per wound requirements.
The North American region accounts for the largest share of the global Acellular Dermal Matrices market in terms of value. This can be attributed to factors such as rising healthcare expenditure, availability of advanced treatment options, and presence of major market players in the region. The Asia Pacific region is projected to be the fastest-growing market during the forecast period owing to large patient pool, increasing medical tourism, and growing adoption of advanced wound management solutions.
The Middle Eastern and African region is also expected witness steady growth owing to rising awareness about advanced wound care therapies and improving access to healthcare facilities across many countries. However, lack of adequate reimbursement policies and low per capita healthcare spends, especially in the African nations, remains a major challenge for widespread adoption of ADM in the region currently.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
